Page last updated: 2024-08-26

artenimol and Prostatic Neoplasms, Castration-Resistant

artenimol has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, S; Luo, Z; Xiang, T; Xu, G; Zou, W	1

Other Studies

1 other study(ies) available for artenimol and Prostatic Neoplasms, Castration-Resistant

Article	Year
Effect of dihydroartemisinin on UHRF1 gene expression in human prostate cancer PC-3 cells. Anti-cancer drugs, 2017, Volume: 28, Issue:4 Topics: Apoptosis; Artemisinins; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Male; Prostatic Neoplasms, Castration-Resistant; RNA, Messenger; S Phase; Ubiquitin-Protein Ligases; Up-Regulation	2017

Article

Year

Effect of dihydroartemisinin on UHRF1 gene expression in human prostate cancer PC-3 cells.

Anti-cancer drugs, 2017, Volume: 28, Issue:4

Topics: Apoptosis; Artemisinins; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Down-Regulation; G1 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Male; Prostatic Neoplasms, Castration-Resistant; RNA, Messenger; S Phase; Ubiquitin-Protein Ligases; Up-Regulation

2017